Liquisolid Compacts: A Paradigm in Drug Delivery System
DOI:
https://doi.org/10.37285/ijpsn.2024.17.5.11Abstract
Liquisolid compacts (LSCs) are a fascinating drug delivery technology that offers numerous advantages, particularly for Biopharmaceutical Classification System (BCS) class 2 drugs. In essence, they convert liquid medications into free-flowing, compressible powder forms suitable for tablet production with improved drug release characteristics. Formulation of liquisolid compacts represents a valuable strategy for overcoming solubility challenges, ultimately contributing to the development of an effective and patient-friendly drug delivery system.
Downloads
Keywords:
Liquisolid Compacts, Quality by Design, Central Composite DesignPublished
How to Cite
Issue
Section
References
Jaydip B, Dhaval M, Soniwala MM, Chavda J. Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach. Saudi Pharmaceutical Journal. 2020 Jun 1;28(6):737-45.
Naureen F, Shah Y, Shah SI, Abbas M, Rehman IU, Muhammad S, Goh KW, Khuda F, Khan A, Chan SY, Mushtaq M. Formulation development of mirtazapine liquisolid compacts: Optimization using central composite design. Molecules. 2022 Jun 22;27(13):4005.
Dholakiya A, Dudhat K, Patel J, Mori D. An integrated QbD-based approach of SMEDDS and liquisolid compacts to simultaneously improve the solubility and processability of hydrochloro-thiazide. Journal of Drug Delivery Science and Technology. 2021 Feb 1;61:102162.
Thakkar HP, Vasava D, Patel AA, Dhande RD. Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability. Therapeutic Delivery. 2020 Feb;11(2):83-96.
Vrushali G. Raut, Bharatee P. Chaudhari, Vivekkumar K. Redasani. Influence of Newly Synthesized Superdisintegrant on Dissolution Rate Enhancement of Carbamazepine using Liquisolid Compact Technique. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(2):107-4